Oncology November 2013
Antiangiogenesis Therapy: A New Strategy for Cancer Treatment
Antiangiogenesis therapy represents one of the most significant advances in clinical oncology.
Vorinostat and Romidepsin for the Treatment of Cutaneous T-Cell Lymphoma
Cutaneous T-cell lymphoma is a heterogeneous group of non-Hodgkin's lymphomas that are characterized by T lymphocytes that infiltrate the skin.
Diabetes October 2013
Individualizing Therapy for the Patient With Type 2 Diabetes
Oncology September 2013
Pharmacy & Technology Supplement
Oncology July 2013
Generic Drug Review June 2013
Oncology May 2013
Oncology March 2013
Oncology January 2013
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.